Avegant logo

Avegant

Developing next-generation display technology to enable previously impossible consumer augmented reality experiences

30 employees · est. 2012 · San Mateo, United States

VS
Immunowake, Inc. logo

Immunowake, Inc.

Immunowake Inc. is a private, pre-clinical stage biotechnology company focused on cancer drug discovery.

2 employees · est. 2019 · Birmingham, United States

Avegant is the older company (2012 vs 2019); Avegant is the larger of the two.

Side-by-Side Comparison

Avegant Immunowake, Inc.
Founded
2012 older 2019
Headquarters
San Mateo, United States Birmingham, United States
Employees
30 larger 2
Industry
Consumer Electronics, Manufacturing, VR/AR Biotechnology
Funding Stage
Series Unknown Series A
Total Funding
$72.74M $23.00M
Funding Rounds
7 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Augmented Reality, Display Technology, Innovation, Hardware, Venture-backed, Technology Company, Consumer Experiences, Award-winning, Team Collaboration Cancer Drug Discovery, Immunotherapy, Cancer Immunotherapy, Pre-clinical Stage, Antigen-specific T-cells, Immune System, Anti-tumor Responses, Cancer Treatment, Cancer Therapies
Website
avegant.com immunowake.com
Avegant logo

About Avegant

Avegant is a well-funded, venture-backed technology company founded in 2012, headquartered in the United States, and focused on developing next-generation display technology to enable previously impossible consumer augmented reality experiences. The company's slogan emphasizes its commitment to pion...

Immunowake, Inc. logo

About Immunowake, Inc.

Immunowake, Inc. is a private, pre-clinical stage biotechnology company focused on cancer drug discovery. The company's strategy involves harnessing the body’s immune system to identify and kill cancer cells, similar to the way pathogens are targeted. Recent breakthroughs in cancer immunotherapy hav...

We will tell you when either one moves

BounceWatch watches Avegant and Immunowake, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Avegant and Immunowake, Inc. — by email.

Frequently Asked Questions

Avegant — Developing next-generation display technology to enable previously impossible consumer augmented reality experiences. Immunowake, Inc. — Immunowake Inc. is a private, pre-clinical stage biotechnology company focused on cancer drug discovery.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Avegant has raised $72.74M while Immunowake, Inc. has raised $23.00M.
Avegant and Immunowake, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Avegant with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Avegant on 12 Sep 2024, and Immunowake, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy